Tryptophan degradation and serum neopterin concentrations in intensive care unit patients

References

• Adamik B, Kübler-Kielb J, Golebiowska B, Gamian A, Kübler A. 2000. Effect of sepsis and cardiac surgery with cardiopulmonary bypass on plasma level of nitric oxide metabolites, neopterin, and procalcitonin: correlation with mortality and postoperative complications. Intensive Care Med 26:1259–1267.
   PubMed Web of Science ®Google Scholar
• Baydar T, Yuksel O, Sahin TT, Dikmen K, Girgin G, Sipahi H, Kurukahvecioglu O, Bostanci H, Sare M. 2009. Neopterin as a prognostic biomarker in intensive care unit patients. J Crit Care 24:318–321.
   PubMed Web of Science ®Google Scholar
• Chen Y, Guillemin GJ. 2009. Kynurenine pathway metabolites in humans: disease and healthy states. Int J Tryptophan Res 2:1–19.
   PubMed Web of Science ®Google Scholar
• Cinel I, Dellinger RP. 2007. Advances in pathogenesis and management of sepsis. Curr Opin Infect Dis 20:345–352.
   PubMed Web of Science ®Google Scholar
• Cotran RS, Kumar V, Collins SL. eds 1999. Robbins Pathologic Basis of Disease, 6th ed. Philadelphia: WB Saunders Co., pp. 113–138.
   Google Scholar
• Fuchs D, Weiss G, Reibnegger G, Wachter H. 1992. The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases. Crit Rev Clin Lab Sci 29:307–341.
   PubMed Web of Science ®Google Scholar
• Haupt W, Riese J, Mehler C, Weber K, Zowe M, Hohenberger W. 1998. Monocyte function before and after surgical trauma. Dig Surg 15:102–104.
   PubMed Web of Science ®Google Scholar
• Hensler T, Sauerland S, Lefering R, Nagelschmidt M, Bouillon B, Andermahr J, Neugebauer EA. 2003. The clinical value of procalcitonin and neopterin in predicting sepsis and organ failure after major trauma. Shock 20:420–426.
   PubMed Web of Science ®Google Scholar
• Huber C, Batchelor JR, Fuchs D, Hausen A, Lang A, Niederwieser D, Reibnegger G, Swetly P, Troppmair J, Wachter H. 1984. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med 160:310–316.
   PubMed Web of Science ®Google Scholar
• Huttunen R, Syrjänen J, Aittoniemi J, Oja SS, Raitala A, Laine J, Pertovaara M, Vuento R, Huhtala H, Hurme M. 2010. High activity of indoleamine 2,3 dioxygenase enzyme predicts disease severity and case fatality in bacteremic patients. Shock 33:149–154.
   PubMed Web of Science ®Google Scholar
• Ip M, Rainer TH, Lee N, Chan C, Chau SS, Leung W, Leung MF, Tam TK, Antonio GE, Lui G, Lau TK, Hui DS, Fuchs D, Renneberg R, Chan PK. 2007. Value of serum procalcitonin, neopterin, and C-reactive protein in differentiating bacterial from viral etiologies in patients presenting with lower respiratory tract infections. Diagn Microbiol Infect Dis 59:131–136.
   PubMed Web of Science ®Google Scholar
• King NJ, Thomas SR. 2007. Molecules in focus: indoleamine 2,3-dioxygenase. Int J Biochem Cell Biol 39:2167–2172.
   PubMed Web of Science ®Google Scholar
• Knaus WA, Draper EA, Wagner DP, Zimmerman JE. 1985. APACHE II: a severity of disease classification system. Crit Care Med 13:818–829.
   PubMed Web of Science ®Google Scholar
• Laich A, Neurauter G, Widner B, Fuchs D. 2002. More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC. Clin Chem 48:579–581.
   PubMed Web of Science ®Google Scholar
• Lin E, Calvano SE, Lowry SF. 2005. Systemic response to injury and metabolic support. In: Brunicardi FC, Andersen DK, Billiar TR, Dunn DL, Hunter JG, Pollock RE, eds. Schwartz’s Principles of Surgery, 8th ed. New York: McGraw Hill, pp. 4.
   Google Scholar
• Meisner M, Tschaikowsky K, Palmaers T, Schmidt J. 1999. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 3:45–50.
   PubMed Web of Science ®Google Scholar
• Mitaka C. 2005. Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome. Clin Chim Acta 351:17–29.
   PubMed Web of Science ®Google Scholar
• Munn DH, Mellor AL. 2007. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest 117:1147–1154.
   PubMed Web of Science ®Google Scholar
• Pellegrin K, Neurauter G, Wirleitner B, Fleming AW, Peterson VM, Fuchs D. 2005. Enhanced enzymatic degradation of tryptophan by indoleamine 2,3-dioxygenase contributes to the tryptophan-deficient state seen after major trauma. Shock 23:209–215.
   PubMed Web of Science ®Google Scholar
• Ploder M, Spitter A, Schroecksnadel K, Neurauter G, Pelinka LE, Roth E, Fuchs D. 2009a. Accelerated tryptophan degradation in trauma and sepsis patients is related to pro-inflammatory response and to the diminished in vitro response of monocytes. Pteridines 20:54–61.
   Web of Science ®Google Scholar
• Ploder M, Spittler A, Schroecksnadel K, Neurauter G, Pelinka LE, Roth E, Fuchs D. 2009b. Tryptophan degradation in multiple trauma patients: survivors compared with non-survivors. Clin Sci 116:593–598.
   PubMed Web of Science ®Google Scholar
• Ruokonen E, Ilkka L, Niskanen M, Takala J. 2002. Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaesthesiol Scand 46:398–404.
   PubMed Web of Science ®Google Scholar
• Schroecksnadel K, Wirleitner B, Winkler C, Fuchs D. 2006. Monitoring tryptophan metabolism in chronic immune activation. Clin Chim Acta 364:82–90.
   PubMed Web of Science ®Google Scholar
• Strohmaier W, Redl H, Schlag G, Inthorn D. 1987. d-Erythro-neopterin plasma levels in intensive care patients with and without septic complications. Crit Care Med 15:757–760.
   PubMed Web of Science ®Google Scholar
• Tattevin P, Monnier D, Tribut O, Dulong J, Bescher N, Mourcin F, Uhel F, Le Tulzo Y, Tarte K. 2010. Enhanced indoleamine 2,3-dioxygenase activity in patients with severe sepsis and septic shock. J Infect Dis 201:956–966.
   PubMed Web of Science ®Google Scholar
• Taylor MW, Feng GS. 1991. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 5:2516–2522.
   PubMed Web of Science ®Google Scholar
• Toussaint S, Gerlach H. 2009. Activated protein C for sepsis. N Engl J Med 361:2646–2652.
   PubMed Web of Science ®Google Scholar
• Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. 1989. Tumour necrosis factor-alpha and lipopolysaccharide enhance interferon-induced tryptophan degradation and pteridine synthesis in human cells. Biol Chem Hoppe-Seyler 370:1063–1069.
   PubMed Web of Science ®Google Scholar
• Widner B, Werner ER, Schennach H, Wachter H, Fuchs D. 1997. Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem 43:2424–2426.
   PubMed Web of Science ®Google Scholar
• Widner B, Wirleitner B, Baier-Bitterlich G, Weiss G, Fuchs D. 2000. Cellular immune activation, neopterin production, tryptophan degradation and the development of immunodeficiency. Arch Immunol Ther Exp (Warsz) 48:251–258.
   PubMedGoogle Scholar
• Wirleitner B, Reider D, Ebner S, Böck G, Widner B, Jaeger M, Schennach H, Romani N, Fuchs D. 2002. Monocyte-derived dendritic cells release neopterin. J Leukoc Biol 72:1148–1153.
   PubMed Web of Science ®Google Scholar
• Yao YM, Yu Y, Wang YP, Tian HM, Sheng ZY. 1996. Elevated serum neopterin level: its relation to endotoxemia and sepsis in patients with major burns. Eur J Clin Invest 26:224–230.
   PubMed Web of Science ®Google Scholar